When it comes to scaling the biobased industries, two pieces of infrastructure matter most: pilot plants and demo plants.
One country actively investing across capacity in both is Thailand.
Over the last few years, the country has been building facilities where biobased producers can test ideas and prove marketability.
Here are the major Thai biobased test facilities and how they slot into the government’s broader policies around biomanufacturing.
What are pilot and demo plants?
Pilot and demo capacity is fundamental to growing the bioeconomy. These sites, effectively small-scale industrial plants, are where producers turn lab discoveries into products.
Pilot plants enter the equation early on in the commercialisation process. They are sites where innovators can test the technical performance of prototypes fresh out of the lab.
At pilot plants, producers can manufacture higher volumes of a material or chemical than is possible in a lab setting. This is the first step towards bringing that product to market.
Demo facilities, meanwhile, allow testing on a much bigger scale. They also come later in the commercialisation process. It is where companies validate products which are potentially on the cusp of market entry.
Once a process is running at a bigger scale, it becomes clear how costly it will be to run at industrial scale and whether it can be profitable.
Together, pilots and demos enable companies to tweak production and assess its economic viability.
A test case
Despite their importance, limited demo and pilot capacity remains one of the biggest barriers to biomanufacturing expansion worldwide.
The reasons why it has been hard to attract private investment into biobased testing become clear when we look at the story of one demo site in Thailand.
In 2022, Blackwood Technology launched a solid biofuels testing site in Lampang province. The site allows clients to test their torrefaction processes – a treatment method that turns low-grade biomass into solid biofuels or biochemicals.
Torrefied biomass can help lower emissions in sectors that are more difficult to electrify, for example by replacing coal in power stations, steel plants and coal-to-gasification plants.
Blackwood and its co-operator TTCL offer on-site equipment that accepts diverse feedstocks. This includes wood like pine and poplar but also agro-wastes like straw, coconut shells, and almond shells.
The conundrum of biobased infrastructure
TTCL and Blackwood invested in the demo plant to plug a gap in the market. Scaling was not happening in the solid biofuels because end-users were reluctant to sign long-term offtakes for untested torrefied pellets.
Consumers wanted proof that the manufacturing process was capable of turning out quality products consistently – a must for a product sold as a drop-in replacement for coal.
Adding to the problem, investors were reluctant to invest in demo plants in case end-user demand did not materialise. This impasse meant a lack of proper testing facilities.
This chicken-and-egg conundrum is common when building new supply chains: new markets need new infrastructure, but few are willing to take the risk of building them alone.
In this sense, Blackwood and TTCL took a leap of faith in setting up their torrefication demo site, judging there would be enough demand to justify the investment.
When it comes to de-risking projects like this, however, there’s no match for government support. In response, the Thai state has been making pilot plant build-out a bioeconomy policy priority.
Thailand’s iBIG initiative
2022 saw another big announcement in the biobased pilot space: the Bio Base Asia Pilot Plant (BBAPP) was coming to Thailand’s Eastern Economic Corridor of Innovation (EECi), Rayong province.
This project is a joint venture between Bio Base Europe Pilot, which operates pilot services in Belgium, and Thailand’s National Science and Technology Development Agency (NSTDA).
Bio Base Asia signalled the Thai government’s willingness to invite foreign investment to bolster testing capacity. Yet despite a promised start in 2024, there has been little word on the project since.
The Thai government’s independent initiatives, meanwhile, have been more fruitful.
The site for the planned Bio Base Asia pilot is already occupied by one of Southeast Asia’s biggest biobased scaling facilities: a pilot plant operated by the Industrial Bioprocess Innovation Group (iBIG).
iBIG was an initiative of the Thai Ministry of Science and Technology, the agency behind the innovation corridor where the plant is located.
Offering clients everything from developing and optimising biomanufacturing processes to actually manufacturing products, iBIG’s site is designed to be a one-stop shop for bio-innovators.
The pilot plant is just one part of a multi-building hub that includes a smart greenhouse, a plant cell and tissue culture lab, and a wet lab. Capacity at the food-compliant plant covers biochemicals, biomaterials, nutraceuticals, and functional ingredients.
Its services even extend to regulatory consultancy, which guides clients through local and international laws governing biorefinery operations and marketing.
PMUC’s nationwide network
Biobased testing facilities elsewhere in Thailand got a boost from the government in 2025.
A Royal Decree geared towards competitiveness and innovation was released. One of its most important implementing agencies is the Program Management Unit for Competitiveness (PMUC) – now Thailand’s most important body for pilot plant development.
PMUC is focused in particular on 7 sectors, two of which fall squarely into the bioeconomy: one bioenergy, biochemicals, and biomaterials, the other functional ingredients and high-value agro-products.
PMUC was mandated with helping industry develop high-value goods and services for the global market, including by investing in national infrastructure that helps advance this goal.
With its target on high-value biomanufacturing as well as building national infrastructure, it was only natural that the unit has been investing into a nation-wide network of so-called “prototype factories”.
PMUC’s facilities
PMUC’s “prototype factories”, which mainly serve the foodtech sector, allow private companies to test innovations at a bigger scale than the laboratory. These sites are located at 9 universities throughout the country.
One of the PMUC-backed pilot-scale facilities is the BIOTEC Bioprocessing Facility. Located in Thailand Science Park, Pathum Thani province. It specialises in testing microbial technologies for the food ingredients sector.
The food-grade facility allows various kinds of testing including media formulation, fermentation, separation, purification, drying, product formulation, product evaluation, product quality auditing and product registration.
It also complies with international health and safety standards, aligning with the government’s focus on building up high-value biobased exports.
Another bio-refinery pilot focused on export-friendly R&D is located at Suranaree University of Technology in Nakhon Ratchasima Province. Launched in 2020, it was the first pilot facility of its kind in northeast Thailand.
The site facilitates R&D in biochemicals, bioplastics, and bioenergy from feedstocks like cassava and sugarcane. The focus on food crops falls in line with the government’s aim to extract more value from Thailand’s large agricultural sector.
An indicative research project at the Suranaree pilot worked on making biochemicals like xylitol from bagasse, a waste byproduct from sugar harvesting.
The goal of these agro-waste technologies is to boost domestic chemicals supply chains while generating revenue. Valorising agro-waste in ways that cuts imports while boosting exports is a priority for institutions like this.
Like other pilots in the country, the team there offers innovators more than just access to testing equipment. The organisation also provides consultation on the technical aspects of biomanufacturing pilots.
Already, the plant’s team has consulted for private companies on topics like sugar production, fermentation, membrane filtration, adsorption, and more.
What pilots like this bring to the table is hands-on experience in manufacturing biochemicals at scale – the ability to identify and anticipate problems relating to real-world scale-up is just as important as the machinery they provide.
The policy pull
Last year, a report commissioned by the Good Food Institute identified Thailand as one of the best places in the world to set up biomanufacturing sites.
Reasons included the government’s biotech tax incentives, low operating costs, and the high availability of sugar feedstock.
These factors have led to increased biomanufacturing capacity in the country, making it one of the fastest-growing biobased producers in Asia.
Advanced testing capacity is becoming another draw for biobased investors. Innovators wanting to scale will find a growing number of pilot facilities throughout the country to choose from, particularly for those interested in exploiting local agro-waste.
As well as providing access to costly equipment, research teams at pilot plants can also bring valuable expertise. Lab-work is one thing but the ability to optimise production comes from hands-on experience with particular machinery and feedstocks.
Pilot plants can also offer location-specific expertise, such as how to work local feedstock like sugar and cassava. Their teams are also versed in biobased regulations, offering short-cuts for resource-pressured startups. In short, pilot plants are more than test sites: they are knowledge sharing centres.
By plugging away at the problem of pilot capacity, Thailand continues to make a name for itself as a rising biomanufacturing destination.


